ACAD
ACADIA Pharmaceuticals Inc
Price:  
15.88 
USD
Volume:  
1,846,599.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Acadia Relative Valuation

-102.0%
Upside

As of 2024-06-25, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is (0.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.88 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is -102.0%.

The range of the Relative Valuation is (0.32) - (0.31) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 30.5x - 31.5x 30.6x
Forward P/E multiples 26.5x - 28.9x 28.9x
Fair Price (0.32) - (0.31) (0.31)
Upside -102.0% - -101.9% -102.0%
15.88 USD
Stock Price
(0.31) USD
Fair Price

Acadia Relative Valuation - Historical P/E Data

Date P/E
2024-06-24 -1,500.97
2024-06-21 -1,446.15
2024-06-20 -1,394.16
2024-06-18 -1,405.50
2024-06-17 -1,402.67
2024-06-14 -1,409.29
2024-06-13 -1,426.30
2024-06-12 -1,452.76
2024-06-11 -1,420.63
2024-06-10 -1,406.45
2024-06-07 -1,407.39
2024-06-06 -1,446.15
2024-06-05 -1,448.04
2024-06-04 -1,460.33
2024-06-03 -1,444.26
2024-05-31 -1,427.24
2024-05-30 -1,417.79
2024-05-29 -1,381.87
2024-05-28 -1,426.30
2024-05-24 -1,436.70
2024-05-23 -1,468.83
2024-05-22 -1,495.30
2024-05-21 -1,443.31
2024-05-20 -1,427.24
2024-05-17 -1,397.94
2024-05-16 -1,403.61
2024-05-15 -1,429.13
2024-05-14 -1,404.56
2024-05-13 -1,434.81
2024-05-10 -1,441.42
2024-05-09 -1,437.64
2024-05-08 -1,619.12
2024-05-07 -1,630.46
2024-05-06 -1,606.83
2024-05-03 -1,611.56
2024-05-02 -1,614.39
2024-05-01 -1,611.56
2024-04-30 -1,579.42
2024-04-29 -1,616.28
2024-04-26 -1,579.42
2024-04-25 -1,541.61
2024-04-24 -1,568.08
2024-04-23 -1,582.26
2024-04-22 -1,605.89
2024-04-19 -1,589.82
2024-04-18 -1,613.45
2024-04-17 -1,624.79
2024-04-16 -1,614.39
2024-04-15 -1,596.43
2024-04-12 -1,620.06